Research plays a crucial role in advancing medicine and science, often leading to groundbreaking discoveries like penicillin, the theory of relativity, or gene editing. While new treatments and ideas often capture our attention, sometimes research is equally valuable for reminding us of truths we may have overlooked or resisted. This week, research on the weight regain seen after stopping tirzepatide (Zepbound), a popular weight loss drug, is one such reminder.
Zepbound, a medication that mimics the effects of GLP-1 (a hormone that regulates blood sugar), has shown incredible results in helping people achieve significant weight loss—up to 50 pounds in one year, based on a Phase 3 clinical trial. Along with weight loss, many users have experienced improvements in health conditions like diabetes, fatty liver disease, and sleep apnea. However, a new study raised an important question: What happens when people stop taking Zepbound?
The answer is unfortunately all too familiar: the majority of participants regain the weight they lost, and many experience reversals in health improvements such as waist size, blood pressure, and cholesterol levels.
83% of participants regained a significant amount of weight—more than 25% of what they had lost.
Many also saw negative changes in health metrics like waist circumference and cholesterol levels.
Weight regain and health issues often began almost immediately after treatment stopped.
This pattern is consistent with other weight loss methods, from diets to bariatric surgery. Over the years, new treatments have provided temporary weight loss, only to be followed by inevitable weight regain once the treatment ends.
Why Does Weight Regain Happen?
Research, such as findings from the National Weight Loss Registry, shows that while weight regain is common, some people do manage to keep the weight off. The key seems to be ongoing lifestyle changes:
- Regular meal times and portion control without following a specific diet.
- Consistent exercise routines.
- Frequent self-weighing.
- Reducing sedentary behaviors like watching TV or using social media.
This research reinforces an important lesson: long-term weight loss requires long-term commitment. Whether through lifestyle changes, ongoing medication, or maintaining post-surgery nutritional guidelines, successful weight maintenance requires continuous effort.
For most people, managing weight loss is a lifelong challenge against biology. Fat cells are not just passive storage; they release hormones that increase hunger and reduce feelings of fullness, especially after weight loss. These hormonal signals can trigger weight regain long after the weight loss phase ends. Additionally, the brain’s reward system, which evolved to prioritize survival, is also designed to favor weight regain, making it harder for people to sustain weight loss over time.
Overweight and Obesity as Chronic Diseases
The recent findings about weight regain after stopping Zepbound underscore a deeper truth about obesity. Much like we know that physical fitness declines when we stop exercising or that relationships need ongoing care, weight loss requires ongoing maintenance.
Science and healthcare have only recently started to recognize that excess body fat—obesity and overweight—is a chronic condition requiring lifelong management. It wasn’t until 2013 that the American Medical Association officially classified obesity as a chronic disease. This shift in thinking took time, but now it’s crucial for the public to understand that healthy weight loss is not a short-term project.
The next step is to change how we approach weight loss, viewing it not as a temporary goal, but as a lifelong journey. Embracing this mindset will help create long-term solutions, leading to sustainable weight loss and better health for everyone. Let’s start this journey today.
Related topic：
